In marked contrast, PFD treatment had no effect in RGS2-siRNA-NIH3T3, indicating that upregulated RGS2 is a important mediator of the anti-fibrotic effects associated with PFD treatment (Fig. 6E–G). This evidence concerns the gene RGS2 and polyostotic fibrous dysplasia.